Term
|
Definition
|
|
Term
|
Definition
| A1 antagonist, used for impaired bladder emptying |
|
|
Term
|
Definition
| B1 antagonist, redistribute myocardial blood in MI, helps with migraines. |
|
|
Term
|
Definition
| B antagonist, open angle glaucoma. |
|
|
Term
|
Definition
| B antagonist, can stimulate beta receptors, open angle glaucoma. |
|
|
Term
|
Definition
| A1 antagonist, B antagonist |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| A1 antagonist, B antagonist |
|
|
Term
|
Definition
| B antagonist, open-angle glaucoma. |
|
|
Term
|
Definition
| B antagonist, open-angle glaucoma |
|
|
Term
|
Definition
| B1 antagonist, redistribute myocardial blood in MI, helps with migraines |
|
|
Term
|
Definition
| B antagonist, helps with migraines. |
|
|
Term
|
Definition
| B antagonist, can stimulate B receptors |
|
|
Term
|
Definition
| A antagonist, treats severe hypertension before surgery. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| B antagonist, can stimulate B receptors |
|
|
Term
|
Definition
| A1 antagonist, acts on baroceptors in CNS, decreases sympathetic outflow |
|
|
Term
|
Definition
| B antagonist, redistribute myocarial blood in MI, prevents hyperthyroidsm, helps with migraines. |
|
|
Term
|
Definition
| A1 antagonist, used for impaired bladder emptying |
|
|
Term
|
Definition
| A1 antagonist, used for impaired bladder emptying. |
|
|
Term
|
Definition
| B antagonist, resdistribute myocardial blood in MI, open-angle glaucoma, helps with migraine. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| A2 antagonist, used to treat impotence. |
|
|
Term
|
Definition
| released from all preganglionic nerves, somatic nerves, parasympathetic postganglionic nerves and some sympathetic nerves. Activates Nm, Nn and M receptors. highly sensative to cholinesterase.acts on presynaptic receptors to inhibit release |
|
|
Term
|
Definition
| M antagonist, parasympathetic block, used for anesthetic premedication, inhibition of saliva and respiratory secretions. high does CNS effects. SE, no spit, no see, no pee, no poo. long lasting mydriasis and cycloplegia |
|
|
Term
|
Definition
| reversible inhibitor of AcH release, binds to synaptobrevin, can treat spasmotic ocular movements |
|
|
Term
|
Definition
| blocks N-type Ca channels, inhibits vesicle release. |
|
|
Term
|
Definition
| Nn antagonist, autonomic blockade. |
|
|
Term
|
Definition
| promotes Ca release into nerve terminal, massive AcH release. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Nicotinic agonist as well as AcH Esterase inhibitor. used for GI atony, urine retention, inhibition of AcH E for neuromuscular disorders, blocks competative NM blocking drugs. |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| act on presynaptic receptors to inhibit AcH release. |
|
|
Term
|
Definition
| Acts on presynaptic receptors to inhibit AcH release. |
|
|
Term
|
Definition
| blocks fast Na channels, prevents Ap conduction. |
|
|
Term
|
Definition
| Nm and Nn antagonist, paralysis. massive histamine release ( Decrease Bp, increase secrtions, bronchoconstirct) |
|
|
Term
|
Definition
| Nicotinic and muscarinic activity, used for open-angle glaucoma. |
|
|
Term
|
Definition
| reversible high-affinity, AcH Esterase inhibitor, used for neuromuscular disorders. |
|
|
Term
|
Definition
| M agonist, most activity on GI and bladder, used for GI atony (lack of tone) |
|
|
Term
|
Definition
| Nn, Nm, M agonist. acts most on GI and bladder. used for induction of miosis and open-angle glucoma. |
|
|
Term
|
Definition
| selective M1/M3 agonist. parasympathetic gland secretion, don't use peptic ulcer, acid. |
|
|
Term
|
Definition
| reversible long-acting AcH Esterase agent. used for open-angle glaucoma. |
|
|
Term
| diisopropyl phosphofluoridate |
|
Definition
| irreversible very lipid soluble, AcH Esterase inhibitor |
|
|
Term
|
Definition
| reversible AcH esterase inhibitor that enters CNS. |
|
|
Term
|
Definition
| irreversible low-toxic, low lipid solubility, AcH esterase inhibitor, used for open-angle glaucoma. |
|
|
Term
|
Definition
| reversible short acting AcH esterse inhiitor, used to diagnose myashtenia gravis, IV use. |
|
|
Term
|
Definition
| reverisble AcH esterase inhibitor that enters CNS. |
|
|
Term
|
Definition
| irreversible AcH esterase inhibitor used as insecticide. |
|
|
Term
|
Definition
| M agonist, weak AcH E substrate, strongest CV activity. constricts lungs for bronchial provocation test. |
|
|
Term
|
Definition
| AcH E reactivator. only use with irreversible inhibitors quickly, weak inhibition of AcH E. |
|
|
Term
|
Definition
| irreversible AcH E inhibitor used as insecticide. |
|
|
Term
|
Definition
| reversible lipd soluble AcH E inhibitor. used with narrow angle and open angle glaucoma, reduces anti-musclarine SE in CNS and peripheral |
|
|
Term
|
Definition
| M agonist, activates sweat glands, don't use with peptic ulcer because acid secretion, reverses mydriais caused by other agents, used in narrow angle and open angle glaucoma. |
|
|
Term
|
Definition
| AcH E reacvitvaor, only used with irreversible inhibitors quickly, weak inhibtion of AcH E. |
|
|
Term
|
Definition
| reversible AcH E inhibitor, used with neuromuscular disorders. |
|
|
Term
|
Definition
| reversible AcH E inhibitor that enters CNS. |
|
|
Term
|
Definition
| M antagonist with CNS activity, antitremor medicaiton used for parkinsons |
|
|
Term
|
Definition
| M antagonist, less duration and cycloplegia. mydriaisi induction |
|
|
Term
|
Definition
| M antagonist. M3 selective, fewer CNS effects. |
|
|
Term
|
Definition
| M antagonist, antisposmotic, decreases excessive Gi motility. |
|
|
Term
|
Definition
| M antagonist, decreased duration and cycloplegia, used for mydriasis induction. |
|
|
Term
|
Definition
| M antagonist, used for bronchodialation, very poorly absorbed, used in aerosol, little effect on mucocillary function. |
|
|
Term
|
Definition
| M antagonist, antispasmotic, used for unstable bladder condtions, causes dry mouth |
|
|
Term
|
Definition
| M antagonist, antispasmotic activity.used for GI hypermotility. |
|
|
Term
|
Definition
| M antagonist, CNS activity, antitremor (parkinsons), treats motion sickness, abuse potential, anethetic premedication, causes mydriasis and cycloplegia. |
|
|
Term
|
Definition
| M antagonist, bladder specific blockage. |
|
|
Term
|
Definition
| M1/M3 antagonist, long duration. used as aerosol for bronchiodialtion, poor absorbtion. |
|
|
Term
|
Definition
| M antagonist, bladder specific block, metabolized by P450, many drug interactions, bad with elderly. |
|
|
Term
|
Definition
| M antagonist, decreased duration and cycloplegia. mydriasis induction |
|
|
Term
|
Definition
| M antagonist, bladder specific. |
|
|
Term
|
Definition
| Nm antagonist, 30-60 min duration, causes histamine release |
|
|
Term
|
Definition
| Nm antagonist, 30-60 min duration, clears spontaneously. |
|
|
Term
|
Definition
| used to treat hyperthermia inducded by succinylcholine, caused by mutation in some. |
|
|
Term
|
Definition
| Nm antagonist, 90-120 min duration, causes histamine release. |
|
|
Term
|
Definition
| Nn blocking drug, autonomic blockade. |
|
|
Term
|
Definition
| Nn blocking drug, autonomic blockade. active orally and can enter CNS. |
|
|
Term
|
Definition
| Nm antagonist, 12-18 min duration, histamine release, metabolized by AcH E |
|
|
Term
|
Definition
| Nm antagonist, 120-180 min duration, ganglionic blockade action (also effects Nn some) |
|
|
Term
|
Definition
| Nm antagonist, 30-60 min duration |
|
|
Term
|
Definition
| Nn blocking drug. used for BP control, short half life and quick onset. |
|
|
Term
|
Definition
| Nm antagonist, 60-90 min duration |
|
|
Term
|
Definition
| Depolarizing Nm Antagonist, histamine release(decrease BP, bronchoconstrict) , last 5-8 mins, depolarizes endplate so it can't act then competative inhibtion, acts on chest/abdomin first then extremities. Metabolized by butryrlcholinesterase. could cause hypercalemia(cardiac arrest), maligant hyperthermia, |
|
|
Term
|
Definition
| binds to rocuronium, vercuronium and pancuronium, inhibiting these agents and reducing paralysis time. |
|
|
